These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 7973107)

  • 1. Effect of high-dose salbutamol on cardiac rhythm in severe chronic airflow obstruction: a controlled study.
    Hall IP; Woodhead MA; Johnston ID
    Respiration; 1994; 61(4):214-8. PubMed ID: 7973107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of beta 2-adrenoceptor agonists on plasma potassium and cardiopulmonary responses on exercise in patients with chronic obstructive pulmonary disease.
    Yang CT; Lin HC; Lin MC; Wang CH; Lee CH; Kuo HP
    Eur J Clin Pharmacol; 1996; 49(5):341-5. PubMed ID: 8866625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Air-driven nebulised high-dose salbutamol in severe chronic obstructive airways disease: is it safe?
    Lai CK; Legge JS; Friend JA
    Respiration; 1991; 58(5-6):249-54. PubMed ID: 1792412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-dose inhaled albuterol in severe chronic airflow limitation.
    Vathenen AS; Britton JR; Ebden P; Cookson JB; Wharrad HJ; Tattersfield AE
    Am Rev Respir Dis; 1988 Oct; 138(4):850-5. PubMed ID: 2462383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination of theophylline and salbutamol for arrhythmias in severe COPD.
    Eidelman DH; Sami MH; McGregor M; Cosio MG
    Chest; 1987 Jun; 91(6):808-12. PubMed ID: 2438095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Salbutamol inhalation has no effect on myocardial ischaemia, arrhythmias and heart-rate variability in patients with coronary artery disease plus asthma or chronic obstructive pulmonary disease.
    Rossinen J; Partanen J; Stenius-Aarniala B; Nieminen MS
    J Intern Med; 1998 May; 243(5):361-6. PubMed ID: 9651558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atropine methonitrate and salbutamol in chronic airways obstruction: peak effect and duration of action.
    Starke ID; Parker RA; Turner-Warwick M
    Respiration; 1982; 43(1):51-6. PubMed ID: 7089390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of reversibility of airway obstruction in patients with chronic obstructive airways disease.
    Nisar M; Walshaw M; Earis JE; Pearson MG; Calverley PM
    Thorax; 1990 Mar; 45(3):190-4. PubMed ID: 2330551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bronchodilator response to nebulized salbutamol in elderly patients with stable chronic airflow limitation.
    Geraghty R; Foster C; Black D; Roe S
    Respir Med; 1993 Jul; 87(5):375-8. PubMed ID: 8209057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High dose salbutamol in chronic airflow obstruction: comparison of nebulizer with Rotacaps.
    Assoufi BK; Hodson ME
    Respir Med; 1989 Sep; 83(5):415-20. PubMed ID: 2616824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and tolerability of high-dose formoterol (via Aerolizer) and salbutamol in patients with chronic obstructive pulmonary disease.
    Rosenkranz B; Rouzier R; Kruse M; Dobson C; Ayre G; Horowitz A; Fitoussi S
    Respir Med; 2006 Apr; 100(4):666-72. PubMed ID: 16303295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of nebulized albuterol on serum potassium and cardiac rhythm in patients with asthma or chronic obstructive pulmonary disease.
    Dickens GR; McCoy RA; West R; Stapczynski JS; Clifton GD
    Pharmacotherapy; 1994; 14(6):729-33. PubMed ID: 7885977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the effect of inhaled selective and non-selective adrenergic agonists on cardiorespiratory parameters in chronic stable asthma.
    Williams AJ; Weiner C; Reiff D; Swenson ER; Fuller RW; Hughes JM
    Pulm Pharmacol; 1994 Aug; 7(4):235-41. PubMed ID: 7620239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paradoxical response to nebulised salbutamol in wheezy infants, assessed by partial expiratory flow-volume curves.
    Prendiville A; Green S; Silverman M
    Thorax; 1987 Feb; 42(2):86-91. PubMed ID: 3433245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nebulised salbutamol without oxygen in severe acute asthma: how effective and how safe?
    Douglas JG; Rafferty P; Fergusson RJ; Prescott RJ; Crompton GK; Grant IW
    Thorax; 1985 Mar; 40(3):180-3. PubMed ID: 3983885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The pulmonary and extra-pulmonary effects of high-dose formoterol in COPD: a comparison with salbutamol.
    Goldkorn A; Diotto P; Burgess C; Weatherall M; Holt S; Beasley R; Siebers R
    Respirology; 2004 Mar; 9(1):102-8. PubMed ID: 14982610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Supine hypoxemia following nebulizated salbutamol in patients with chronic airway obstruction.
    Pinet C; Ferrer R; Tessonnier F; Orehek J
    Lung; 2001; 179(5):259-63. PubMed ID: 11976894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of salbutamol on lung function and chest wall volumes at rest and during exercise in COPD.
    Aliverti A; Rodger K; Dellacà RL; Stevenson N; Lo Mauro A; Pedotti A; Calverley PM
    Thorax; 2005 Nov; 60(11):916-24. PubMed ID: 15994253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison between fenoterol/ipratropium bromide combinations and salbutamol administered as nebulizer solution assessing dose-response and duration of action.
    McIntosh D
    Respiration; 1986; 50 Suppl 2():310-2. PubMed ID: 2951827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute hemodynamic and arrhythmogenic effects of high-dose intravenous salbutamol in patients with chronic left ventricular dysfunction.
    Rotstein Z; Battler A; Rath S; Perek J; Eldar M
    Clin Cardiol; 1990 Jul; 13(7):468-72. PubMed ID: 2364580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.